Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asahi Ito

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Cancer Immunology, Immunotherapy : CII|December 3, 2008
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse modelAsahi Ito, Takashi Ishida, Hiroki Yano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 8, 2019
[Richter syndrome successfully treated with ibrutinib monotherapy: two case reports]Haruna Fujinami, Shigeru Kusumoto, Ayako Masaki, et al.
Blood|February 11, 2012
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphomaHiroyoshi Nishikawa, Yuka Maeda, Takashi Ishida, et al.
International Journal of Hematology|January 31, 2015
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapyHaruhito Totani, Shigeru Kusumoto, Takashi Ishida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2019
Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-LymphomaYui Suzuki, Masato Saito, Toshihiko Ishii, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2009
Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivoAsahi Ito, Takashi Ishida, Atae Utsunomiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2022
Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assayShinya Hagiwara, Shigeru Kusumoto, Takako Inoue, et al.
Leukemia Research|October 3, 2012
Angioimmunoblastic T-cell lymphoma mice modelFumihiko Sato, Takashi Ishida, Asahi Ito, et al.
Ejhaem|July 18, 2022
Volunteer unrelated donor cell-derived acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Shinya Hagiwara, Shigeru Kusumoto, Asahi Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2013
HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantationTomoko Narita, Takashi Ishida, Ayako Masaki, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Cancer Immunology, Immunotherapy : CII|December 3, 2008
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse modelAsahi Ito, Takashi Ishida, Hiroki Yano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 8, 2019
[Richter syndrome successfully treated with ibrutinib monotherapy: two case reports]Haruna Fujinami, Shigeru Kusumoto, Ayako Masaki, et al.
Blood|February 11, 2012
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphomaHiroyoshi Nishikawa, Yuka Maeda, Takashi Ishida, et al.
International Journal of Hematology|January 31, 2015
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapyHaruhito Totani, Shigeru Kusumoto, Takashi Ishida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2019
Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-LymphomaYui Suzuki, Masato Saito, Toshihiko Ishii, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2009
Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivoAsahi Ito, Takashi Ishida, Atae Utsunomiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2022
Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assayShinya Hagiwara, Shigeru Kusumoto, Takako Inoue, et al.
Leukemia Research|October 3, 2012
Angioimmunoblastic T-cell lymphoma mice modelFumihiko Sato, Takashi Ishida, Asahi Ito, et al.
Ejhaem|July 18, 2022
Volunteer unrelated donor cell-derived acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Shinya Hagiwara, Shigeru Kusumoto, Asahi Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2013
HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantationTomoko Narita, Takashi Ishida, Ayako Masaki, et al.
Pageof 7